Literature DB >> 14501701

In vitro assessment of ultrasonic lithotriptors.

Ramsay L Kuo1, Ryan F Paterson, Tibério M Siqueira, Andrew P Evan, James A McAteer, James C Williams, James E Lingeman.   

Abstract

PURPOSE: Ultrasonic lithotriptors are commonly used to fragment and remove stones during percutaneous nephrolithotomy. To date a comparative assessment of current units has not been accomplished without potential operator bias. An objective testing environment is required for optimal appraisal of the efficiency of ultrasonic lithotriptors.
MATERIALS AND METHODS: An in vitro test system was devised to evaluate the ability of ultrasonic lithotriptors to core through artificial stones. The system consisted of an irrigation sheath (Cook Urological, Spencer, Indiana) through which ultrasonic probes were placed. Ultrasonic hand pieces and probes were secured in an upright position. An Ultracal-30 (U.S. Gypsum, Chicago, Illinois) stone cylinder (mean length 12.8 +/- 0.6 mm, mean diameter 7.6 +/- 0.07 mm) was centered on the probe tip. A weight (62.7 gm) was placed atop the stone to provide a constant force. We evaluated the Olympus LUS-1 and LUS-2 (Olympus, Melville, New York), Circon-ACMI USL-2000 (Circon-ACMI, Southborough, Massachusetts), Karl Storz Calcuson (Karl Storz, Culver City, California) and Richard Wolf model 2271.004 (Richard Wolf, Vernon Hills, Illinois). All probes had outer diameters of 3.4 mm except for the Circon-ACMI unit (3.8 mm). Using 100% power settings times for complete stone penetration were assessed for all units. Differences in mean stone penetration times were compared using ANOVA.
RESULTS: The Olympus LUS-2 had the fastest mean stone penetration time (28.8 +/- 2.7 seconds). This value was used to normalize the data into efficiency ratios, where other unit times were expressed as multiples of the LUS-2 time: Olympus LUS-2 (1.0 +/- 0.1) equals Circon-ACMI USL-2000 (1.1 +/- 0.3) greater than Karl Storz Calcuson (1.4 +/- 0.3) greater than Olympus LUS-1 (2.1 +/- 0.5) greater than Richard Wolf (3.6 +/- 0.8). Efficiencies of the LUS-2 and USL-2000 units were essentially equivalent, with all others significantly less efficient (p <0.05).
CONCLUSIONS: This new in vitro testing model provides an objective, reproducible method for evaluating the efficiency of intracorporeal lithotriptors. Of the units tested the Olympus LUS-2 and Circon-ACMI USL-2000 were the most efficient.

Mesh:

Year:  2003        PMID: 14501701     DOI: 10.1097/01.ju.0000088021.44446.d7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Histotripsy erosion of model urinary calculi.

Authors:  Alexander P Duryea; Timothy L Hall; Adam D Maxwell; Zhen Xu; Charles A Cain; William W Roberts
Journal:  J Endourol       Date:  2010-11-22       Impact factor: 2.942

2.  Ultracal-30 gypsum artificial stones for research on the mechanisms of stone breakage in shock wave lithotripsy.

Authors:  James A McAteer; James C Williams; Robin O Cleveland; Javier Van Cauwelaert; Michael R Bailey; David A Lifshitz; Andrew P Evan
Journal:  Urol Res       Date:  2005-12

3.  In Vitro Assessment of Three Clinical Lithotripters Employing Different Shock Wave Generators.

Authors:  Stuart Roy Faragher; Robin O Cleveland; Sunil Kumar; Oliver J Wiseman; Benjamin W Turney
Journal:  J Endourol       Date:  2016-02-26       Impact factor: 2.942

Review 4.  Intracorporeal lithotripsy.

Authors:  Peter Alken
Journal:  Urolithiasis       Date:  2017-12-04       Impact factor: 3.436

5.  In vitro comminution of model renal calculi using histotripsy.

Authors:  Alexander P Duryea; Adam D Maxwell; William W Roberts; Zhen Xu; Timothy L Hall; Charles A Cain
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2011-05       Impact factor: 2.725

6.  In vitro evaluation of the Lithoclast Ultra Vario combination lithotrite.

Authors:  Jonathan N VonDerHaar; James A McAteer; James C Williams; James E Lingeman
Journal:  Urol Res       Date:  2010-10-22

Review 7.  Surgical management of stones: new technology.

Authors:  Brian R Matlaga; James E Lingeman
Journal:  Adv Chronic Kidney Dis       Date:  2009-01       Impact factor: 3.620

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.